EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nonsteroidal Approaches for Atopic Dermatitis®: A Clinical Update

Peter Y Ch'en iD, Peter A Lio iD

Dermatitis® · 2024

DOI: 10.1089/derm.2023.0373 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Dermatitis®, 2024. Verfasst von Peter Y Ch'en und 1 weiteren Autor:innen. Beteiligte Einrichtung: From the Division of Dermatology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Dermatitis, Atopic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 88 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Topical corticosteroids (TCSs) are the most widely used treatment for atopic Dermatitis® (AD), but they can have adverse effects such as skin atrophy, telangiectasias, and hypopigmentation, especially with prolonged use of higher potency steroids. Many patients also have a fear of using TCSs, known as “corticophobia.” With the development of biologics and Janus kinase inhibitors, a nonsteroidal approach to the treatment of AD may be possible and may be preferred by certain patients. Given what is known about these nonsteroidal therapies, we propose a structured treatment ladder and action plan that can guide clinicians and patients on the use of these therapies for the treatment of AD. The ladder divides nonsteroidal medication classes into treatments for exacerbation versus maintenance therapies in an escalating order of increasing potential for adverse effects, both real and perceived. This treatment algorithm proposal paves the way for a potential nonsteroidal approach to managing AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Inflammatory Agents, Non-SteroidalDermatitis, AtopicHumansAdministration, CutaneousAdrenal Cortex HormonesBiological ProductsDermatologic AgentsJanus Kinase Inhibitors

Substanzen

Adrenal Cortex HormonesAnti-Inflammatory Agents, Non-SteroidalBiological ProductsDermatologic AgentsJanus Kinase Inhibitors

Autor:innen und Institutionen

  • From the Division of Dermatology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Medical Dermatology Associates of Chicago, Chicago, Illinois, USA.

ORCID-Profile: Peter Y Ch'en, Peter A Lio

Zitieren

APA

Ch'en, P. Y., & Lio, P. A. (2024). Nonsteroidal Approaches for Atopic Dermatitis®: A Clinical Update. Dermatitis®. https://doi.org/10.1089/derm.2023.0373

Vancouver

Ch'en PY, Lio PA. Nonsteroidal Approaches for Atopic Dermatitis®: A Clinical Update. Dermatitis®. 2024. doi:10.1089/derm.2023.0373

BibTeX
@article{Chen2024,
  author = {Ch'en, Peter Y and Lio, Peter A},
  title = {Nonsteroidal Approaches for Atopic Dermatitis®: A Clinical Update},
  journal = {Dermatitis®},
  year = {2024},
  doi = {10.1089/derm.2023.0373}
}
Kostenlos starten →